Cue Biopharma, Inc. (CUE)
NASDAQ·Healthcare·Biotechnology
$12.84
-28.42%
Mkt Cap $47.12M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 16, 2026 | $1.00M | $21.94M | +2094.20% | -$0.09 | $0.01 | +111.11% | — | — |
| Q4 2025 Nov 12, 2025 | $2.29M | $2.15M | -6.14% | -$0.10 | -$0.07 | +30.00% | — | — |
| Q3 2025 Aug 12, 2025 | $2.29M | $2.95M | +29.01% | -$0.13 | -$0.09 | +30.77% | — | — |
| Q2 2025 May 12, 2025 | $1.27M | $421.00K | -66.79% | -$0.14 | -$0.17 | -21.43% | — | — |
| Q1 2025 Mar 31, 2025 | $1.70M | $1.58M | -7.36% | -$0.16 | -$0.13 | +18.75% | — | — |
| Q4 2024 Nov 14, 2024 | $1.70M | $3.34M | +96.10% | -$0.20 | -$0.17 | +15.00% | — | — |
| Q3 2024 Aug 14, 2024 | $1.29M | $2.66M | +106.05% | -$0.29 | -$0.20 | +31.03% | — | — |
| Q2 2024 May 9, 2024 | $1.21M | $1.72M | +41.90% | -$0.30 | -$0.25 | +16.67% | — | — |
| Q2 2024 Apr 8, 2024 | $1.00M | $1.82M | +82.10% | -$0.28 | -$0.28 | +0.00% | — | — |
| Q4 2023 Nov 9, 2023 | $2.24M | $2.10M | -6.25% | -$0.30 | -$0.24 | +20.00% | — | — |
| Q3 2023 Aug 8, 2023 | $910.00K | $1.38M | +51.87% | -$0.30 | -$0.29 | +3.33% | — | — |
| Q2 2023 May 9, 2023 | $1.95M | $187.00K | -90.41% | -$0.33 | -$0.29 | +12.12% | — | — |
| Q1 2023 Mar 21, 2023 | $100.00K | $151.23K | +51.23% | -$0.32 | -$0.37 | -15.62% | — | — |
| Q4 2022 Nov 14, 2022 | $513.50K | $68.00K | -86.76% | -$0.38 | -$0.31 | +18.42% | — | — |
| Q3 2022 Aug 4, 2022 | $1.13M | $26.00K | -97.70% | -$0.42 | -$0.37 | +11.90% | — | — |
| Q2 2022 May 10, 2022 | $3.05M | $1.00M | -67.26% | -$0.43 | -$0.44 | -2.33% | — | — |
| Q1 2022 Mar 16, 2022 | $1.14M | $8.25M | +624.70% | -$0.25 | -$0.26 | -4.00% | — | — |
| Q4 2021 Nov 9, 2021 | $2.05M | $2.40M | +16.83% | -$0.39 | -$0.41 | -5.13% | — | — |
| Q3 2021 Aug 9, 2021 | $2.74M | $2.74M | +0.00% | -$0.42 | -$0.33 | +21.43% | — | — |
| Q2 2021 May 17, 2021 | $1.43M | $1.55M | +8.57% | -$0.37 | -$0.41 | -10.81% | — | — |